Iterum Therapeutics

0.03
Open
0.04
Market Cap
1.60M+
High
0.05
Low
0.03
Close
0.03
Volume
65.74M+
P/E Ratio
-0.02
Div/Yield
0.00%

About Iterum Therapeutics

Iterum Therapeutics plc 是一家臨床階段的製藥公司,在愛爾蘭、百慕大和美國從事抗感染藥物的開發和商業化。它正在開發磺胺培南,這是一種新型抗感染化合物,具有口服和靜脈注射劑型,目前正處於 III 期臨床試驗階段,用於治療無並發症的尿路感染、複雜的尿路感染和復雜的腹腔內感染。該公司成立於 2015 年,總部位於愛爾蘭都柏林。

如何購買 Iterum Therapeutics (ITRM)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 ITRM

購買 ITRM

透過 RockFlow App 或網頁端搜尋 ITRM,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.